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Abstract
The spinal dorsal horn contains numerous inhibitory interneurons that control transmission of somatosensory information. Although
these cells have important roles in modulating pain, we still have limited information about how they are incorporated into neuronal
circuits, and this is partly due to difficulty in assigning them to functional populations. Around 15% of inhibitory interneurons in
laminae I-III express neuropeptide Y (NPY), but little is known about this population. We therefore used a combined
electrophysiological/morphological approach to investigate these cells in mice that express green fluorescent protein (GFP) under
control of the NPY promoter. We show that GFP is largely restricted to NPY-immunoreactive cells, although it is only expressed by
a third of those in lamina I-II. Reconstructions of recorded neurons revealed that they were morphologically heterogeneous, but
never islet cells. Many NPY-GFP cells (including cells in lamina III) appeared to be innervated by C fibres that lack transient receptor
potential vanilloid-1, and consistent with this, we found that some lamina III NPY-immunoreactive cells were activated bymechanical
noxious stimuli. Projection neurons in lamina III are densely innervated by NPY-containing axons. Our results suggest that this input
originates from a small subset of NPY-expressing interneurons, with the projection cells representing only a minority of their output.
Taken togetherwith results of previous studies, our findings indicate that somatodendriticmorphology is of limited value in classifying
functional populations among inhibitory interneurons in the dorsal horn. Because many NPY-expressing cells respond to noxious
stimuli, these are likely to have a role in attenuating pain and limiting its spread.
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1. Introduction
Inhibitory interneurons, which account for;30% of the neurons in
laminae I-III of the spinal dorsal horn,44 are important in controlling
the transmission of sensory inputs perceived as pain or
itch2,11,12,31,51,61 and represent potential targets for treatments
designed to relieve these symptoms. Despite intensive investiga-
tion, we still know relatively little about their organisation or about
the synaptic circuits through which they modulate sensory trans-
mission. This is largely due to the difficulty in identifying distinct
populations among these cells.14,61 A widely used morphological
classification scheme for lamina II interneurons defines 4 major
classes: islet, central, vertical, and radial,15 with islet cells and some
central cells corresponding to inhibitory interneurons.76 However,
most studies of lamina II neurons have found that ;25% of these
cells could not be classified morphologically,15,19,76 and little is
known about the relation between morphology and function for
interneurons in laminae I and III.49,54
The complex neurochemistry of the dorsal horn provides an
alternative way of defining neuronal populations, and we have
identified 4 largely nonoverlapping classes among the inhibitory
interneurons in laminae I-III, defined by the expression of neuronal
nitric oxide synthase (nNOS), galanin, neuropeptide Y (NPY), and
parvalbumin.46 These classes differ in their responses to noxious
stimuli and are believed to have different roles in modulating
sensory transmission. For example, parvalbumin cells are
involved in presynaptic inhibition of low-threshold mechanore-
ceptive afferents,24 whereas the galanin cells, which also express
dynorphin,3,52 may contribute to prevention of mechanical
allodynia.11 In addition, it has been suggested that the nNOS
and/or galanin populations play a part in inhibiting itch.31
Little is known about the NPY-expressing cells, although NPY
itself has a complex role in nociception.4 For example,NPYacting at
the spinal level has been reported to increase thermal nociceptive
thresholds in naive animals21 and to reduce hyperalgesia in both
inflammatory and neuropathic models.26,60 However, it has also
been found that NPY can exacerbate hyperalgesia after peripheral
nerve injury.65,70 The NPY-expressing cells are all GABA
immunoreactive and account for ;15% of the inhibitory
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interneurons in laminae I-III in the rat.47 It has been shown in the
mouse that their development is dependent on the transcription
factors Ptf1a and Pax2, which determine inhibitory fate,3,22,71 and
that they represent a developmentally distinct population among the
inhibitory interneurons.3 We have previously shown that many
NPY1neurons in the rat respond to noxious stimuli46 and that NPY-
immunoreactive axons, presumably derived from local NPY-
expressing interneurons, selectively innervate a population of
anterolateral tract (ALT) projection neurons in lamina III.5,47,48 In
this study, we have investigated NPY-expressing interneurons in
laminae I-III of themouse.Specifically,we testedwhether these cells
correspond to any of the morphologically defined classes15 and
whether they are innervated by unmyelinated primary afferents,
most of which are nociceptors.We also looked for evidence that the
NPY cells that innervate lamina III ALT neurons represent a distinct
subpopulation.47
2. Methods
Experiments were approved by the Ethical Review Process
Applications Panel of the University of Glasgow and were
performed in accordance with the U.K. Animals (Scientific
Procedures) Act 1986.
The mouse line B6.FvP-Tg(Npy-hrGFP)1Lowl/J (The Jackson
Laboratory, Stock number 006417),67 which expresses human-
ized Renilla green fluorescent protein (GFP) under control of the
NPY promoter, was used for most of the experiments in this
study. These mice (which will be referred to as NPY-GFP) were
maintained as heterozygous (University of Glasgow Biological
Services) by crossing with wild-type C57Bl/6 mice, and the
resulting offspring were genotyped using transcranial illumination
to visualise GFP expression in the brain at P3-4.
2.1. Immunocytochemical assessment of NPY-GFP mice
Five NPY-GFPmiceof either sex, aged27 to42days (13-17g, similar
to theage rangeused in theelectrophysiological studies),weredeeply
anaesthetised with pentobarbitone (30 mg intraperitoneally) and
perfused through the left ventricle with a fixative that contained 4%
freshly depolymerised formaldehyde. Spinal cord segments L3-L4
werepostfixedovernight andcut into transverse sections60mmthick
with a vibrating blade microtome VT1200 or VT1000S, Leica, Milton
Keynes, United Kingdom). The sections were then processed for
immunocytochemistry, as described previously.13 In all cases,
sections were incubated in primary antibodies for 3 days and in
secondary antibodies for 1 day, in both cases at 4˚C. All antibodies
were diluted in phosphate-buffered saline (PBS) that contained 0.3M
NaCl, 0.3% Triton-X100, and 5% normal donkey serum. Species-
specific secondary antibodies (Jackson ImmunoResearch, West
Grove,PA)were raised indonkeyandconjugated toRhodamineRed,
DyLight 649, Alexa 647,PacificBlue, or biotin. Biotinylated secondary
antibodies were revealed by incubation for 2 to 4 hours in avidin
conjugated to Pacific Blue (Life Technologies, Paisley, United
Kingdom).
Sections were reacted with each of the following combinations
of primary antibodies: (1) rabbit anti-NPY and mouse monoclonal
antibody NeuN; (2) rabbit anti-galanin, sheep anti-nNOS, and
guinea-pig anti-parvalbumin. Sections from 3 mice were reacted
for each antibody combination, and those from the first combina-
tion were counterstained with 49,6-diamidino-2-phenylindole to
reveal nuclei. The sources of the primary antibodies and their
dilutions are shownTable 1. After completion of immunoreactions,
sections were mounted in antifade medium and stored at 220˚C.
Sections were scanned with a Zeiss LSM 710 confocal
microscope equipped with argon multiline, 405 nm diode, 561
nm solid state, and 633 nm HeNe lasers, and a spectral detection
system. In each case, confocal image stacks (z-separation of 1 or
2 mm) were obtained through a 403 oil-immersion lens (numerical
aperture 1.3) with the aperture set to 1 Airy unit. The resulting z-
stacks were analysed with Neurolucida for Confocal software (MBF
Bioscience, Williston, VT).
To assess the extent of overlap between GFP and NPY,
confocal z-stacks obtained from a single section (scanned at
1 mm z-separation) from each of 3 mice were analysed using
amodification of the optical disectormethod.45 In each series, the
14th optical section was designated as the reference section and
the 35th as the look-up. Each optical section in the z-series was
examined, and the locations of all neuronal nuclei that were NPY
immunoreactive and/or GFP1 and were present in the reference
section or appeared in subsequent sections in the series were
plotted onto an outline of the dorsal horn. All of those that were still
present on the look-up section were then excluded, leaving only
those neurons for which the bottom surface of the nucleus was
located between reference and look-up sections.
To determine whether any of the GFP1 neurons were
immunoreactive for galanin, nNOS, or parvalbumin, 2 sections
from each of 3 mice were scanned through their full thickness (at
2 mm z-separation) and the channel corresponding to GFP was
initially viewed. All GFP1 neurons in laminae I-III were plotted onto
an outline drawing. The other channels were then viewed, and the
presence or absence of galanin, nNOS, or parvalbumin
immunoreactivities was noted.
2.2. Slice preparation and electrophysiology
Spinal cord slices were obtained from 68 NPY-GFP mice 4 to 6
weeks old of either sex. As described previously,10,13,27 the lumbar
spinal cordwas isolated either after laminectomy performed during
anaesthesia with isoflurane (1%-3%) or else in ice-cold dissection
solution after decapitation under brief isoflurane anaesthesia. Mice
Table 1
Antibodies used in this study.
Antibody Species Dilution Source Catalogue number
NPY Rabbit 1:1K Bachem, Bubendorf, Switzerland T-4070
NeuN Mouse 1:1K Millipore, Watford, United Kingdom MAB377
Galanin Rabbit 1:1K Bachem T-4334
nNOS Sheep 1:2K PC Emson
PV Guinea pig 1:2500 M Watanabe
PKCg Guinea pig 1:500 M Watanabe
CGRP Guinea pig 1:10K Peninsula International Laboratories Inc,
San Carlos, CA
T-5027
pERK Mouse 1:500 Cell Signaling Technology, Danvers, MA 9106
CGRP, calcitonin gene-related peptide; nNOS, neuronal nitric oxide synthase; NPY, neuropeptide Y; pERK, phosphorylated extracellular signal-regulated kinase; PKCg, protein kinase C–g; PV, parvalbumin.
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from which the spinal cord had been removed under anaesthesia
were then immediately decapitated. The spinal cord was trans-
ferred to ice-cold dissecting solution containing the following (in
mM): 3.0 KCl, 1.2 NaH2PO4, 0.5 to 2.4 CaCl2, 1.3 to 7.0 MgCl2,
26.0 NaHCO3, 15.0 to 25.0 glucose, 240.0 to 251.6 sucrose,
oxygenatedwith 95%O2 and 5%CO2, and the dura and piamater
were removed. For experiments that involved dorsal root
stimulation, the L4 and L5 dorsal roots (with ganglia removed)
were left attached to the cord. The spinal cord was cut into
parasagittal (300-500 mm) or transverse (350 mm) slices with
a vibrating blade microtome (MicromHM 650V; Fisher Scientific,
Loughborough, United Kingdom), and these were then allowed to
recover at room temperature for at least 30 minutes in recording
solution that contained the following (in mM): 125.8 to 127.0 NaCl,
3.0 KCl, 1.2 NaH2PO4, 2.4 CaCl2, 1.3 MgCl2, 26.0 NaHCO3, 15
glucose, oxygenated with 95% O2 and 5% CO2. Although most
recordings were made in parasagittal slices, for some experiments
involving dorsal root stimulation, transverse sections were used as
this method of cutting can generate more slices with attached
dorsal roots.
Targeted whole-cell patch-clamp recordings were made from
GFP-positive neurons that were visualized under fluorescence
and infrared differential interference contrast microscopy on an
Olympus BX51WI microscope. Patch pipettes were pulled with
a horizontal puller (P-97; Sutter Instruments, Novato, CA) from
glass capillaries (World Precision Instruments or Harvard Appa-
ratus). Typical pipette electrical resistance was 4 to 7 MV when
filled with internal solution, which usually contained the following
(in mM): 130.0 potassium gluconate, 10.0 KCl, 2.0 MgCl2, 10.0
HEPES, 0.5 EGTA, 2.0 ATP-Na2, 0.5 GTP-Na, and pH adjusted
to 7.3 with 1.0 M KOH. In some experiments that involved dorsal
root stimulation, internal solution containing the following (in mM):
120.0 Cs-methylsulfonate, 10.0 Na-methylsulfonate, 10.0 EGTA,
1.0 CaCl2, 10.0 HEPES, 5.0 QX-314-Cl[2(triethylamino)-N-(2,6-
dimethylphenyl) acetamine chloride], 2.0 Mg2-ATP, pH adjusted
to 7.2 with CsOH was used instead. In all cases, Neurobiotin
(0.2%; Vector Laboratories, Peterborough, United Kingdom) was
included in the internal solution for subsequent morphological
analysis of recorded cells. Patch-clamp signals were amplified
and filtered (4 kHz low-pass Bessel filter) with a MultiClamp 700B
amplifier (Molecular Devices) and acquired at 10 kHz using
a Digidata 1440A or 1550 A/D board and pClamp 10 software
(Molecular Devices, Wokingham, United Kingdom).
After successful configuration of whole-cell mode, cells were
voltage clamped at 260 mV. Short voltage pulses (100 milli-
seconds, 270 to 250 mV, 2.5 mV increments) were delivered to
generate current–voltage (I-V) relationships for recorded cells, and
those that exhibited restingmembranepotentialsmore depolarised
than230mVwere not analysed further. Current-clampmode was
used to examine the pattern of action potential firing. Cells were
sometimes presented with continuous bias currents to return
membrane potentials to around260 mV, and depolarising square
current pulses (1 second) of increasing amplitude were applied.
To investigate primary afferent input to the neurons, evoked
excitatory postsynaptic currents (eEPSCs) were recorded in spinal
cord slices with attached dorsal roots in response to dorsal root
stimulation, as described previously.13,63,64 Cells were voltage
clamped at 270 mV, and the dorsal root was stimulated with
a suction electrode. To determine the fibre types providing input to
the recorded neurons, stimuli were initially applied at low frequency
(0.05 Hz, stimulus duration 0.1 milliseconds,33) using an ISO-Flex
stimulus isolator (AMPI Intracell), with progressively increasing
intensities. The stimulation intensities used were 25 mΑ for Ab
fibres, 100mA for Ad fibres, and 500mA and 1mA for C fibres. Cells
in which no monosynaptic response was evident at 1 mA were
additionally stimulated at 3 and/or 5 mA. Primary afferent input was
characterized as monosynaptic or polysynaptic in the manner of
Nakatsuka et al,41 as described previously.63,64 Dorsal roots were
stimulated 20 times at 20 Hz for Ab fibres, 2 Hz for Ad fibres, and 1
Hz for C fibres. A-fibre responses were consideredmonosynaptic if
there was an absence of failures and a latency variability of #2
milliseconds, whereas C-fibre responses were classified as mono-
synaptic if there was an absence of failures, regardless of whether
the latency was variable. The estimated conduction velocity for
monosynaptic primary afferent inputs was calculated on the basis
of the response latency, measured as the time between the
stimulus artefact and the onset of the monosynaptic eEPSC, and
the length of the stimulated dorsal root, measured as the distance
between the stimulation electrode and the dorsal root entry zone.
To provide information about monosynaptic inputs from primary
afferents that express transient receptor potential channels and
to allow a comparison with a different population of inhibitory
interneurons (those that express GFP under control of the prion
promoter in the PrP-GFP mouse line; PrP-GFP cells)13 miniature
excitatory postsynaptic currents (mEPSCs) were recorded in the
presence of tetrodotoxin (0.5 mM), bicuculline (10 mM), and
strychnine (5 mM). While the cell was voltage clamped at 260 mV,
capsaicin (2 mM) or icilin (20 mM) was bath applied through 3-way
stopcocks without any change in perfusion rate (approximately 2
mL/min). For experiments with icilin, bath temperature was raised to
32˚C with an in-line heating perfusion tube (HPT-2; ALA Scientific
Instruments, Farmingdale, NY) and a control system (PCT-10, NPI),
as described previously.13 Voltage-clamp recordings were obtained
throughout the period before and during drug application, and
mEPSCs were detected off-line using Mini Analysis Program
software (Synaptosoft, Decatur, GA). The period for analysis was
set to 5 minutes for capsaicin application and 3 minutes for icilin
application, and in both cases, the period of analysis began 2 to
3 minutes after the stopcock was opened, to allow the drugs to
reach the recording chamber (which takes ;2 minutes).
For a subset of cells that received monosynaptic C-fibre input,
the capsaicin sensitivity of this input was assessed.66,74 Mono-
synaptic C-fibre eEPSCs were evoked at 1 mA (0.05 Hz, 0.1
milliseconds stimulus duration) for 10 minutes (baseline) followed
by a further 10 minutes in the presence of capsaicin (2 mM). To
determine whether an individual cell received monosynaptic
C-fibre input that was capsaicin sensitive, peak monosynaptic
C-fibre eEPSC amplitude was measured for each sweep, and the
amplitude of sweeps recorded in the 3 minutes before capsaicin
application was compared with those during the final 3 minutes of
capsaicin application. Tetrodotoxin and icilin were obtained from
Tocris Bioscience, and 1(S),9(R)-(2)-bicuculline methiodide,
strychnine hydrochloride, and capsaicin were from Sigma-Aldrich.
After electrophysiological recording, slices were immersion
fixed overnight in 4% formaldehyde at 4˚C.
2.3. Morphological analysis of recorded neurons
The processing of slices that contained recorded cells and the
reconstruction of these cells with Neurolucida for Confocal software
(MBF Bioscience) were similar to that described previously.13 After
fixation, slices containing recorded cells were rinsed in PBS and
incubated overnight at 4˚C in avidin Rhodamine (1:1000; Jackson
ImmunoResearch) diluted in PBS containing 0.3% Triton X-100.
They were then mounted on slides and scanned with the confocal
microscope. Confocal image stacks of filled cells were acquired by
scanning through a 633 oil-immersion lens (numerical aperture 1.4)
with 0.5mmz-spacing and the aperture set to 1Airy unit. Initial scans
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included all dendritic trees and axonal arbors that were visible at this
stage, and these were analysed offline. In all cases, the presence of
GFP was confirmed by scanning for the native protein within the cell
bodies of the filled neurons. Axons could readily be distinguished
from dendrites because they were generally thinner, showed little
tapering at increasing distance from the soma, lacked spines, and
possessed numerous irregularly spaced varicosities.13,15,76
Initially, the dendritic trees and axonal arbors of the cells were
manually reconstructed with the neuron tracing feature of
Neurolucida. Slices were then flat embedded in agar and
resectioned at 60 mm with a vibrating blade microtome (Leica
VT1200), and the sections were kept in serial order. Sections that
contained parts of the dendritic or axonal tree that were deep
within the slice and had not previously been visible were scanned,
and these were added to the reconstruction. To determine
laminar boundaries, 1 section from each slice was immunos-
tained to reveal protein kinase C–g (PKCg), which is present in
a plexus of dendrites that occupies the inner half of lamina II (IIi).23
The boundaries between the outer part of lamina II (IIo) and lamina
IIi and between laminae IIi and III were added to the reconstruc-
tions, by aligning sections containing the recorded cells with
nearby sections stained for PKCg. The lamina I/IIo border was
taken to be 20 mm below the dorsal white matter,13 and this was
also added to the reconstruction. Morphometric data for cell
bodies, dendritic trees, and axonal arbors of the reconstructed
cells were obtained from Neurolucida Explorer.
To allow a comparison of the somatodendritic morphology of
NPY-GFP cells with that of a neurochemically distinct group of
inhibitory interneurons, we also analysed morphometric data
obtained from PrP-GFP cells.13,17,18 In the PrP-GFP mouse, GFP
is found exclusively in inhibitory interneurons in the dorsal horn and
is virtually restricted to those that express nNOS and/or galanin.27
We performed a cluster analysis with Ward’s method,69 using 55
morphological parameters (6 for the soma and 49 for the dendritic
tree) that were obtained from the Neurolucida reconstructions.
Because the PrP-GFP cells are mainly present in lamina II, this
analysis was performed on those NPY-GFP cells with well-labelled
dendritic trees and cell bodies in lamina II (n 5 20), together with
a population of 70 lamina II PrP-GFP cells that were recorded
during a previous study from our laboratory.13 To reduce the
dimensionality of the original data set while preserving variance,
principal components were calculated from the data set with the
factor analysis function of SPSS software (IBM). The number of
principal components to be retained for cluster analysis was then
determined from a scree test.
To determine whether the recorded neurons included those
that innervate lamina III ALT neurons,47,48 we selected 38 of the
cells and identified sections that contained a significant part of
their axonal arbor. These sections were immunostained with
rabbit anti-NPY and guinea pig antibody against calcitonin gene-
related peptide (CGRP), which were revealed with Alexa 647 and
Pacific Blue, as described above. This combination of antibodies
was chosen because both of these peptides are present in
bundles of axons that are associated with the cell bodies and
dendrites of the lamina III ALT neurons.5 We also tested for the
presence of detectable NPY immunoreactivity in axons of the
filled cells. These were defined as NPY-immunoreactive if there
was immunostaining for the peptide in at least 5 boutons.13
2.4. pERK in NPY-immunoreactive neurons
To test whether any NPY-expressing lamina III neurons in
the mouse respond to noxious mechanical stimuli, we performed
immunocytochemistry for phosphorylated extracellular
signal-regulated kinases (pERK), a well-established marker of
neuronal activation,28,29 on transverse sections of spinal cord from
3 male wild-type C57Bl/6 mice (17 g) that had received a pinch
stimulus to the left hindpaw as part of a previous study.57 These
animals were initially anaesthetised with isoflurane and maintained
with 10% urethane (intraperitoneally). Folds of skin on the plantar
surface of the hindpaw (over the tarsal bones) were pinched at 10
locations (5 seconds each) with watchmakers’ forceps, and 5
minutes after the last stimulus the animals were perfused with 4%
formaldehyde. Sections from the lumbar enlargement were
reacted with antibodies against pERK, NPY, and PKCg, which
were revealed with fluorescent secondary antibodies. Three or 4
sections that contained numerous pERK1 cells were selected from
each animal (before NPY immunostaining was viewed) and
scanned with the confocal microscope through the 403 lens to
produce z-stacks (2 mm z-separation) through the full thickness of
the tissue. The z-scans were analysed with Neurolucida, and the
band of PKCg-immunoreactive dendrites was used to define the
laminae II-III border, while the depth of lamina III was taken to be
100 mm. We used phosphorylation of ERK, rather than the
transcription factor Fos,25 to identify activated cells because we
have found that this method results in more consistent labelling in
the dorsal horn after noxious mechanical stimuli.43,46
2.5. Antibody characterisation
The NPY antibody was raised against synthetic NPY, and we have
previously reported that staining is abolished by pretreatment with
NPY.50 In addition, we have found that staining is absent in mice in
which NPY has been knocked out56 (AJT and H Herzog,
unpublished observations). The NeuN antibody was raised against
cell nuclei extracted from mouse brain and found to react with
a protein specific for neurons,38 which has subsequently been
identified as the splicing factor Fox-3.32 The galanin antibody was
raised against the synthetic peptide, and staining is absent in the
brains of galanin-knockout mice.35 The nNOS antibody was raised
against purified recombinant rat nNOSand labels a bandof 155 kDa
in Western blots of rat hypothalamus, while immunostaining is
abolishedby preabsorptionwith nNOS.20 Theparvalbumin antibody
is directed against the mouse protein and recognises a band of 13
kDa on Western blots of mouse brain homogenates.40 The PKCg
antibody, which was raised against amino acids 648 to 697 of the
mouse protein, detects a single band at 75 kDa in wild-type (but not
PKCg2/2) mice and stains identical structures to those detected by
a well-characterised rabbit antibody.53,77 The CGRP antibody
detects both a and b forms of the peptide (manufacturer’s
specification). The monoclonal pERK antibody detects both ERK1
andERK2 that are dually phosphorylated at Thr202andTyr204 sites
and does not cross-react with either JNK or p38 MAP kinase that is
phosphorylated at the corresponding sites (manufacturer’s speci-
fication). Staining with this antibody was restricted to somatotopi-
cally appropriate areas of the dorsal horn after noxious stimulation.
2.6. Statistics
Miniature EPSC interevent intervals in control conditions were
compared to those in the presence of drugs by the Kolmogorov–
Smirnov 2-sample test. Dorsal root eEPSC amplitudes in the
presenceor absenceof capsaicinwere comparedwith theWilcoxon
matched-pairs signed-rank test. Dendritic spine density for lamina II
and lamina III neuronswascomparedwith theMann–WhitneyU test,
while other differences in anatomical properties of neurons in the 2
laminae were compared with unpaired t-tests. In all cases, a P value
,0.05 was considered significant.
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3. Results
3.1. Expression of GFP in the NPY-GFP mouse dorsal horn
We initially examined the relationship between GFP expression
and NPY immunoreactivity in perfusion-fixed tissue from the NPY-
GFP mouse. Although GFP1 cells were present throughout the
dorsal horn, their density was relatively low in laminae I-II, while they
were more numerous in lamina III (Fig 1A). Comparison with NeuN
staining revealed that all GFP1 cells in laminae I-II and virtually all of
those in lamina III were NeuN immunoreactive, confirming their
neuronal identity (Fig 1B). However, in the deeper dorsal horn and
ventral horn (laminae IV-IX), there were also cells that were weakly
labelled with GFP and lacked NeuN, and these resembled glial
cells. Immunostaining for glial fibrillary acidic protein confirmed that
these were astrocytes (AJT, unpublished data).
Quantitative analysis (Table 2) revealed that the great majority
(85%) of GFP1 cells throughout laminae I-III showed NPY
immunoreactivity in their cell bodies (Figs 1C and D), and similar
results were found when considering laminae I-II (78%) and
lamina III (90%), separately. However, as expected from the
relatively low density of GFP1 cells in the superficial dorsal horn,
these accounted for only 33%of NPY-immunoreactive neurons in
laminae I-II, whereasGFPwas present in 82%of those in lamina III
(Table 2).
In the sections immunostained for galanin, nNOS, and
parvalbumin (Fig 2), between 128 and 180 (mean, 156; n 5 3
mice), GFP1 cells were identified in laminae I-III. None of these
cells were immunoreactive for either nNOSor galanin, while a very
small proportion (1.3%-2.3%; mean, 1.8%) were parvalbumin
immunoreactive. Although we did not use a stereological method
for this analysis, the general lack of colocalisation means that our
results are unlikely to have been affected by any bias towards
cells of different sizes.16
Penetration of all antibodies used in this part of the study was
apparently complete because in each case, immunoreactive cell
bodieswere seenwith approximately equal frequency throughout
the depths of the sections.
3.2. Membrane properties of green fluorescent
protein–positive cells recorded in the NPY-GFP mouse
The subthreshold I-V relationship, determined by giving brief
voltage pulses (100 milliseconds; 270 to 250 mV; 2.5 mV
increments), was used to calculate the resting membrane
potential of each recorded cell. The average value across 96 cells
was251.16 1.0 mV (SEM) with an input resistance of 1433.66
79.8 MV. In current-clamp mode, cells were injected with
incrementing depolarising current in the form of 1 second square
pulses, and the first action potential evoked was analysed in
detail. In 96 cells, the voltage threshold for evoking action
potentials (defined as the point where rate of voltage rise
exceeded 10 mV/milliseconds) was 233.6 6 0.5 mV, the height
of action potentials was 57.46 1.7mV, the base width was 3.66
0.2 milliseconds, and the amplitude of after-hyperpolarisation
was 30.36 1.2 mV. Most recorded cells (89/96 cells, 93%) were
able to generate action potentials repetitively, and these were
defined as tonic (n5 81) or initial bursting (n5 8). A few (7/96, 7%)
only produced 1 or 2 action potentials in response to supra-
threshold current.
3.3. Primary afferent inputs to NPY-GFP cells
Dorsal root stimulation was used to investigate primary afferent
input to 39 of the NPY-GFP neurons, and this resulted in eEPSCs
in 15 cells (38.5%). The remaining cells may have received
primary afferent input from dorsal roots that were not stimulated
or from axons that had been severed during the slice preparation.
Of those cells with primary afferent input, 4 (26.7%) received
polysynaptic C-fibre input only. The remaining 11 cells (73.3%) all
Figure 1. The distribution of green fluorescent protein (GFP) in the
neuropeptide Y (NPY)-GFP mouse and its relation to NPY-immunoreactivity.
(A andB) Themedial part of the dorsal horn in a transverse section from aNPY-
GFP mouse immunostained for NeuN (magenta). The solid line outlines the
grey matter, and the dashed line shows the lamina II-III border. GFP1 cells
(green) are present throughout this region but are more numerous in lamina III.
(C and D) A higher magnification view of the same region scanned to reveal
NPY (magenta) and GFP. NPY–immunoreactivity is present in many small
structures, which correspond to axonal boutons, and also in the cell bodies of
some neurons. Arrows point to 3 GFP1 cells that have NPY-immunoreactivity in
their cell bodies, and the positions of these cells are shownwith the arrows in (A).
The insets showGFP (green) and NPY-immunoreactivity (magenta) separately in
the cell bodies of each of these 3 cells. Note that the NPY staining is located in
clumps within the perikaryal cytoplasm. All parts of the figure are maximum
intensity projections of confocal z-stacks consisting of 46 (A, B) or 5 (C, D) optical
sections at 1 mm z-spacing. Scale bars (A, B): 50 mm; (C, D): 20 mm.
Table 2
NPY expression by GFP cells in laminae I-III.
Laminae GFP (total) NPY-ir (total) GFP 1 NPY-ir % GFP that are NPY-ir % NPY-ir that are GFP
I-III 45.3 (39-52) 71.3 (55-85) 38.7 (33-46) 85.1 (82-89) 54.7 (50-60)
I-II 16.3 (15-17) 39.3 (32-49) 12.7 (11-14) 77.9 (65-87) 33.4 (27-44)
III 29 (22-37) 32 (23-37) 26 (19-33) 89.5 (86-93) 81.5 (70-92)
The numbers and percentages of neurons that were GFP1, NPY-immunoreactive (ir), or both GFP1 and NPY-immunoreactive. Values are means of 3 mice (ranges given in brackets).
GFP, green fluorescent protein; NPY, neuropeptide Y.
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received monosynaptic C-fibre input, with 8 of these cells
receiving additional inputs that were monosynaptic Ad (1 cell),
polysynaptic C (2 cells), polysynaptic Ab (2 cells), and poly-
synaptic Ab with polysynaptic Ad (3 cells). For 4 of the cells with
monosynaptic C input, 2 distinct C-fibre eEPSCs could be
distinguished (Fig 3). Stimulating dorsal roots at an increased
intensity of 3 or 5 mA did not reveal any additional inputs in those
cells that showed no monosynaptic response at 1 mA. The
estimated conduction velocity of the monosynaptic C-fibre input
was 0.146 0.01 m/s, and the corresponding value for the single
monosynaptic Ad-fibre input was 0.49 m/s.
Analysis of mEPSC frequency in response to bath application
of transient receptor potential channel agonists suggested that
most NPY-GFP cells do not receive monosynaptic inputs from
either transient receptor potential vanilloid-1 (TRPV1)-expressing
or transient receptor potential melastatin-8 (TRPM8)-expressing
primary afferents. Application of a TRPV1 agonist, capsaicin (2
mM), led to an increase in mEPSC frequency in only 2 of 12 tested
NPY-GFP cells (Fig 4A). Subsequent morphological analysis
revealed that one of these cells had its soma in lamina IIo, while
the other was in lamina III. The cell bodies of 5 of the cells that did
not respond to capsaicin were identified: 2 of thesewere in lamina
IIi and the other 3 were in lamina III. A TRPM8 agonist, icilin (20
mM), was tested on 8 cells, but none of these showed a significant
increase inmEPSC frequency (Fig 4B). All neurons tested for icilin
were recovered. Two of these had cell bodies located in lamina
IIo, 4 in lamina Iii, and 2 were in lamina III.
The capsaicin sensitivity of the primary afferent input to NPY-
GFP cells was assessed in a subset of those that received
monosynaptic C-fibre input.42,73 Four cells, 2 of which had 2
separate monosynaptic C-fibre inputs, were tested. Application
of capsaicin (2mM) did not alter the peak eEPSC amplitude of any
of the 6 monosynaptic C-fibre inputs (Figs 4C and D), which
suggests that these resulted from activation of unmyelinated
afferents that lacked TRPV1.73 Capsaicin did not evoke inward
currents either in these cells or in those tested in the absence of
dorsal root stimulation (see above).
3.4.Morphology of neurons recorded in theNPY-GFPmouse
Altogether, 65 of the recorded NPY-GFP cells were recon-
structed with Neurolucida, and examples are shown in Figure 5.
In all cases, GFP was detected in the cell body (Fig 5J). Twenty-
three of these cells had their soma in lamina II (4 in lamina IIo and
19 in lamina IIi; Figs 5A–D), while for the remaining 42 cells, the
soma was in lamina III (Figs 5E–I). The axonal arbors of all cells
were well labelled, but in 7 cases (3 in lamina II and 4 in lamina III),
the dendrites were very short and appeared to have been
truncated. These cells were therefore excluded from the
morphometric analysis of dendritic trees. The 58 cells with well-
labelled dendritic trees were morphologically heterogeneous and
did not fit into any of the classes that have been identified in
previous studies.15,75 In particular, none of the recorded neurons
were islet cells, which represent a well-defined class of inhibitory
interneurons.15,19,36,62,76 The laminar locations of dendritic trees
are shown in Table 3. For most cells (41/58), these occupied
laminae II and III, but in 4 cases, they extended into lamina I. A few
of the cells had dendritic trees restricted to a single lamina.
Figure 2. Lack of overlap between green fluorescent protein (GFP) and othermarkers for inhibitory interneuron populations. Confocal scans of a transverse section
from a neuropeptide Y–GFP mouse that had been immunostained for neuronal nitric oxide synthase (nNOS) (red), parvalbumin (PV, blue), and galanin (Gal,
magenta). A–D show 3 GFP1 cells (green, arrows) in lamina IIi-III that are not immunoreactive for either nNOS or PV but are surrounded by cells that are either PV-
immunoreactive (arrowheads) or nNOS-immunoreactive (double arrowheads). (E–G) Part of lamina II from the same section scanned to reveal galanin and GFP. A
GFP1 cell that lacks galanin (arrow) and a galanin-immunoreactive cell that lacks GFP (arrowhead) are shown. A–D consist of 3 optical sections at 1mmz-spacing,
while E–G are from a single optical section. Scale bar 5 20 mm.
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The mean extents of the dendritic trees in rostrocaudal,
dorsoventral, and mediolateral axes were 166, 90, and 50 mm,
respectively (Table 4). This indicates that the cells are somewhat
elongated in the rostrocaudal axis and occupy a relatively narrow
mediolateral depth. When the corresponding values were
compared between the cells with somata in lamina II and lamina
III, the mean dorsoventral extent was found to differ significantly
(68 and 101 mm, respectively; P , 0.01, unpaired t-test). We
noticed that lamina III cells often had dorsally directed dendrites
(eg, Figs 5F, H), and we therefore compared the extent of
the dendritic tree that lay dorsal and ventral to themid-point of the
soma.75 The mean dorsal and ventral dendritic extents for the
lamina III cells were 63 mm (6 36 mm) and 36 mm (6 29 mm),
respectively, and these were significantly different (P , 0.01,
unpaired t-test). A similar comparison for the lamina II cells
showed that the dorsal and ventral dendritic extents did not differ
significantly (dorsal, 386 17mm; ventral, 326 24mm; P5 0.46).
This shows that the dendritic trees of the lamina III cells extend
more dorsally than ventrally from the cell body and are consistent
with the finding that 28 of the 38 lamina III cells had dendrites that
extended into lamina II. In 9 cases, dorsal dendrites of lamina III
cells entered lamina IIo. There was considerable variation in the
complexity of dendritic branching, with some cells having highly
branched dendritic trees (eg, Figs 5B, E) and others having
dendrites that branched sparsely (eg, Figs 5A, H, I). The density
of spines per 100 mm dendritic length varied considerably
(0-13.6; median, 4), but there was no significant difference
between cells in laminae II and III (P 5 0.94, Mann–Whitney
U-test). Morphological datawere available for 9 of the 11 cells that
received monosynaptic C-fibre input (see section 3.3 above), and
Figure 3. Primary afferent input to neuropeptide Y–green fluorescent protein (NPY-GFP) cells tested by dorsal root stimulation. (A and B) Characterisation of
primary afferent input to NPY-GFP cells receivingmonosynaptic C fibre only andmonosynaptic Adwithmonosynaptic C-fibre input, respectively. Left panels show
examples of evoked EPSCS (eEPSCs) resulting from low-frequency (0.05 Hz) dorsal root stimulation at Ab-fibre (25 mA), Ad-fibre (100 mA), and C-fibre (1 mA)
intensities; each trace is an average of 3 recordings. Right panels show examples of eEPSCs resulting from high-frequency dorsal root stimulation (25 mA/20 Hz;
100 mA/2 Hz; 1 mA/1 Hz); each displays 20 superimposed traces. In both examples, 2 monosynaptic C-fibre inputs could be distinguished (each shown with an
arrow). The monosynaptic Ad input is indicated with an arrowhead.
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2 of these are illustrated in Figure 5 (cells C and F). Seven of these
cells had cell bodies in lamina III, while the other 2were in lamina IIi
(eg, Fig 5C). In all cases, dendrites of these cells extended at least
as far as themid-part of lamina II (eg, Fig 5F). Among the cells that
showed capsaicin-resistant monosynaptic C-fibre input, 3 were
located in lamina III and 1 in lamina IIi. Two of these cells were
located in the medial part of the dorsal horn, as judged by the
presence of numerous dorsoventrally orientated myelin bundles.
Inspection of the dendritic trees of the NPY-GFP cells in lamina II
and those of the PrP-GFP cells described in our previous study13
revealed that both populations had highly variable morphology. To
provide an objective comparison, we performed cluster analysis of
these 2 populations, using the morphological parameters listed in
Table 5. A scree test (Fig 6A)6 revealed that the decrease in
eigenvalues reached a plateau at 5 principal components, and
these were therefore used for cluster analysis. However, this
analysis failed to separate the NPY-GFP cells into distinct clusters
(Fig 6B). This suggests that these 2 groups of cells (NPY-GFP and
PrP-GFP) do not belong to populations that are distinct from each
other in terms of the somatodendritic morphology.
Axons of most recorded cells (50/65) arborised in both laminae
II and III, whereas in 4 cases, the axon was restricted to lamina III
(Table 3). Eleven cells had axon entering lamina I, but 8 of these
gave rise to ,5 boutons in this lamina. The extents of axonal
arbors in rostrocaudal, dorsoventral, and mediolateral axes are
shown in Table 4. These were highly variable, with some being
relatively extensive in the rostrocaudal axis (eg, Figs 5B–E),
whereas others extended along both rostrocaudal and dorso-
ventral axes (eg, Figs 5A, F–I). The axonal arbors showed
relatively little spread along the mediolateral axis (Table 4). The
only significant difference between axons of cells in laminae II and
III was that the latter had a greater dorsoventral extent (P, 0.05,
unpaired t-test). Themean total length of the reconstructed axons
for the 65 recorded cells was 4967 6 2117 mm, and these
possessed a mean of 5606 327 boutons, with a bouton density
of 11.15 6 4.07 per 100 mm length.
Figure 4. Effects of transient receptor potential channel agonists. (Ai) Voltage-clamp traces showing that the frequency of miniature EPSCs (mEPSCs) increased
with bath application of capsaicin (2 mM). A significant increase in frequency was observed in 2 of 12 neuropeptide Y–green fluorescent protein (NPY-GFP) cells
tested. (Aii) An example of a cumulative probability plot that shows a significant decrease in mEPSC interevent intervals (ie, an increase in mEPSC frequency). (Aiii)
Changes in the rate of mEPSCs (events/min) with capsaicin application. The grey diamonds represent each cell tested, and the black horizontal bars show the
average across the 12 cells. (Bi) Voltage-clamp traces in control conditions and in the presence of icilin (20 mM). Icilin did not cause any significant increase in
mEPSC frequency in any of the 8 NPY-GFP cells tested. (Bii) An example of a cumulative probability plot showing no significant change in mEPSC interevent
intervals with icilin application. (Biii) The rate of mEPSCs (events/min) in control conditions and in the presence of icilin. Grey diamonds represent the 8 cells tested,
and the black horizontal bar shows the average values. (C and D) Capsaicin sensitivity of monosynaptic C-fibre input to NPY-GFP cells. (C) An example of
monosynaptic C-fibre evoked EPSCs recorded in a NPY-GFP cell before (baseline) and during (capsaicin) application of capsaicin (2 mM). Baseline and capsaicin
traces are an average of 9 recordings, corresponding to the 3minutes before and the final 3minutes of capsaicin application, respectively. (D) Of themonosynaptic
C-fibre inputs tested for sensitivity to capsaicin, all 6 were found to be nonresponsive to capsaicin. Overall, capsaicin did not alter the peak amplitude of
monosynaptic C-fibre input to NPY-GFP neurons (n5 6, P5 0.313,Wilcoxonmatched-pairs signed-rank test). Data presented asmean6 SEM; grey points and
lines indicate trajectories for individual cells.
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We have shown in both rat and mouse that ALT projection
neurons in lamina III are densely innervated by NPY-immunoreactive
boutons that are arranged in clusters that follow the dorsal dendrites
of these cells.5,48 We have also provided evidence that these
originate from a specific subset of NPY-expressing interneurons
because these boutons were significantly larger and more strongly
immunoreactive thanotherNPY-expressingboutons in this region.47
To identify the neurons giving rise to this input, we therefore used
immunocytochemistry and tested whether axons of any of the
recorded cells contributed to the bundles of NPY-immunoreactive
axons that innervate the ALT cells.47,48 The cell bodies and dorsal
dendrites of lamina III ALT cells are also densely innervated by
peptidergic primary afferents, which can be revealedwith antibodies
against CGRP.39 The clusters of NPY axons that are associatedwith
the ALT cells can therefore be recognised by their close association
with bundles of CRGP-immunoreactive primary afferents.5,48
This analysis was performed on 38 of the recorded neurons.
Sections that contained parts of the axonal arbor from the
selected neurons were reacted with antibodies against NPY and
CGRP. In these sections, intermingled bundles of NPY-
immunoreactive and CGRP-immunoreactive axons were clearly
visible in lamina III (Fig 7A), and these could often be followed
dorsally into lamina II. We have shown that these bundles are
associated with lamina III ALT cells retrogradely labelled from the
lateral parabrachial area in the mouse.5 Examination of the
reacted sections revealed that for the great majority of the cells
that were tested (36 of 38), the axon of the recorded neuron did
not contribute to any of these bundles of NPY-immunoreactive
axons. However, in 2 cases, the axon was seen entering these
bundles (Fig 7). In 1 case, 326 boutons were identified on the
labelled axon, and 21 of these (6%) were located within a single
bundle of NPY axons. For the other cell (illustrated in Fig 7), 104 of
340 boutons were located in bundles of NPY axons, and in this
case, the axon was seen to contribute to 3 adjacent bundles,
which were located;150 to 200 mm apart (Figs 7B–D). We also
tested for the presence of NPY immunoreactivity in axonal
boutons belonging to the recorded neurons, and this was found
in 11 of the 38 cells. The lack of detectable NPY immunoreactivity
in the other recorded cells is likely to reflect loss of the peptide,
which can occur during whole-cell recording.13 The 2 cells that
had axons contributing to the NPY bundles both showed strong
NPY immunoreactivity in many of their boutons (Fig 7C’).
3.5. pERK expression by NPY–immunoreactive cells
Because NPY-GFP neurons in lamina III often had dendrites that
extended into lamina II and some of these cells received
monosynaptic input from C fibres, we tested whether NPY-
expressing cells in lamina III responded to noxious stimulation.
Figure 5.Morphology of recorded neuropeptide Y–green fluorescent protein (GFP) cells. (A–I) Examples of Neurolucida reconstructions for 9 of the recorded cells,
4 with cell bodies in lamina II (A–D) and 5 with cell bodies in lamina III (E–I). Cell bodies and dendrites are shown in blue and axons in red. In each drawing, the solid
line indicates the grey-white border, while dashed lines represent the boundaries between laminae I, IIo, Iii, and III. Note the variability in dendritic and axonal
morphology. The cells illustrated in (C) and (F) were both tested with dorsal root stimulation and correspond to (A) and (B) of Figure 4, respectively, and both have
dendrites that arborise extensively in lamina II. (J) A confocal optical section through the soma of the cell illustrated in (B) shows Neurobiotin (magenta) and GFP
(green). D, dorsal; RC, rostrocaudal; V, ventral. Scale bars: A–I, 100 mm; J, 20 mm.
Table 3
Laminar distribution of dendrites and axons of recorded NPY-
GFP neurons.
Laminae Dendritic tree Axonal arbor
I-III 3 (5) 10 (15)
I-II 1 (2) 1 (2)
II 3 (5) 0 (0)
II-III 41 (71) 50 (77)
III 10 (18) 4 (6)
Values are the number (%) of cells that had dendrites or axons that extended into different laminae. Dendritic
trees were analysed for 58 cells, but axonal arbors for 65 cells.
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We used a pinch stimulus because we have found in the rat that
this is particularly effective for generating pERK in lamina III
neurons, including some that are NPY immunoreactive.43 As
reported previously,57 5 minutes after pinching of the skin on the
hindpaw, pERK1 cells were seen in themedial part of the ipsilateral
dorsal horn. The number and distribution of pERK1 cells varied
considerably between sections, presumably reflecting the punc-
tate nature of the pinch stimulus, and for this reason, we did not
determine the proportion of NPY-immunoreactive cells that were
pERK positive. Instead, we counted the total number of pERK1
and double-labelled (pERK1/NPY-immunoreactive) cells in lamina
III in the 3 or 4 sections analysed from each mouse. Between 40
and 68 (mean, 57), pERK1 cells were identified in lamina III in the
3 mice, and between 4 and 9 of these cells were also NPY
immunoreactive, corresponding to a mean of 11.7% (range,
10%-13.2%) of the pERK1 cells. An example is shown in Fig 8.
4. Discussion
The main findings of this study are (1) that NPY-GFP cells are
morphologically diverse and that those in lamina II do not
consistently fit into any of the morphological classes identified in
this lamina,15 (2) that they include a specific subset with axons
that contribute to the dense bundles of NPY axons that are
associated with projection neurons in lamina III, and (3) that most
of them were not innervated by TRPV1-expressing primary
afferents.
4.1. Green fluorescent protein cells in the NPY-GFP mouse
As expected, the great majority of GFP1 cells in laminae I-III were
NPY immunoreactive, and the lack of detectable NPY immuno-
reactivity in a small proportion of the cells probably results from
a low level of peptide in cell bodies of some NPY-expressing
neurons. This interpretation is consistent with the findings of van
den Pol et al,67 who demonstrated that GFP in this mouse line
was restricted to NPY-expressing neurons in several brain areas.
Our finding that only a third of NPY-immunoreactive cells in
laminae I-II expressed GFP was unexpected, and it is not known
whether the GFP1 cells in laminae I-II are representative of all
NPY-expressing interneurons in this region. However, the lack of
colocalisation of GFP with galanin, nNOS, and parvalbumin
clearly indicates that the NPY-GFP cells in laminae I-III are distinct
from other population of inhibitory interneurons in this region.61
This is apparently the first morphological study of NPY-
expressing cells in the dorsal horn and allows comparison with
other neurochemically defined populations. Parvalbumin is
expressed by inhibitory interneurons in laminae IIi and III, and
many of these are islet cells,1,24,33 which indicates a clear
morphological difference from the NPY-GFP neurons. Mesnage
et al37 reported that cholinergic neurons in lamina III, which are
a subset of the nNOS population,59 had a characteristic morpho-
logical appearance, with rostrocaudally elongated dendritic trees
that often extended dorsally, thus resembling some of the lamina III
NPY-GFP cells. We have recently described the morphological
features of inhibitory interneurons that expressGFP in thePrP-GFP
mouse. These cells are mainly located in lamina II,18 and because
98% of them express nNOS and/or galanin,27 they are completely
different from the NPY-GFP population. As with the NPY-GFP
cells, the PrP-GFP cells were morphologically heterogeneous, but
were never islet cells.13 Cluster analysis based on somatodendritic
morphology failed to separate the 2 populations, and it is likely that
neither contains cells with distinctive somatodendritic morphology.
Despite this, there were differences between the populations in
terms of their axonal projections and primary afferent inputs. Unlike
the NPY-GFP cells, most PrP-GFP cells had axons that entered
lamina I. In addition, most PrP-GFP cells showed an increase in
mEPSC frequency after application of capsaicin and around half
did so in response to icilin,13,78 which suggests that they are
generally innervated by TRPV1-expressing nociceptors, and often
by TRPM81 cold-sensitive afferents. In contrast, increased
mEPSC frequency was only seen on 2 of the 12 NPY-GFP cells
tested with capsaicin and none of those tested with icilin.
Therefore, although there are functional differences between the
NPY-GFP and PrP-GFP populations, they cannot be distinguished
based on somatodendritic morphology.
Taken together with the results of previous studies, our findings
suggest that somatodendritic morphology cannot be used to
define functional populations among those inhibitory interneurons
that are not islet cells.
4.2. Innervation of lamina III ALT neurons
Anterolateral tract projection neurons with cell bodies in lamina III
are densely innervated by axons that contain high levels of NPY
and are believed to originate from a specific subset of NPY cells.47
We identified 2 cells that had axons with strong NPY immunore-
activity and contributed to dense bundles of NPY axons that were
intermingled with CGRP bundles, an arrangement associated with
the cell bodies and dendrites of lamina III ALT neurons.5,48 It is
therefore highly likely that these cells innervated ALT neurons.
Cells of this type were rarely identified in our recordings, and
there could be various explanations for this: (1) wemay have failed
to identify contributions to the NPY bundles from other recorded
cells (although this seems unlikely because substantial parts of
the axonal arbor were examined in most cases), (2) cells that
innervate the ALT neurons may account for a small proportion of
the NPY-expressing neurons, (3) they may be underrepresented
among the cells that express GFP in this line, or (4) they may be
relatively difficult to record from.
One of the 2 cells had an axon that contributed to 3 NPY
bundles, which were located over 100 mm apart, and it is
Table 4
Dendritic and axonal extent of recorded NPY-GFP neurons.
Dendritic tree Axonal arbor
Rostrocaudal Dorsoventral Mediolateral Rostrocaudal Dorsoventral Mediolateral
All 166 6 67 90 6 44 50 6 23 390 6 270 145 6 57 69 6 33
Lamina II 171 6 55 68 6 25* 48 6 23 411 6 342 127 6 40† 71 6 41
Lamina III 164 6 73 101 6 48* 51 6 23 378 6 225 156 6 62† 69 6 27
Values are in mm and are mean 6 SD of the extent of the dendritic tree or axonal arbor in each axis.
* Denotes significant difference (P , 0.001).
† Denotes significant difference (P , 0.05).
The number of cells for which dendritic trees were analysed is 57 (21 in lamina II and 36 in lamina III), whereas for axonal arbors, 65 cells were analysed (25 in lamina II and 40 in lamina III).
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Table 5
Morphological parameters used for cluster analysis.
Cell body
Somatic area Area of largest contour used to outline the soma
Somatic perimeter Perimeter of largest contour used to outline the
soma
Somatic aspect ratio Maximum diameter/minimum diameter of
soma
Somatic compactness [((4/p)*area))]1/2/maximum diameter
Somatic roundness (4*area)/(p*maximum diameter2)
Laminar location Location of soma (IIo, IIi)
Dendritic tree
Dendrite number Total number of dendrites
Total dendritic length Total length of dendrite
Average dendritic length Total dendritic length/dendrite number
Total number of branches Total number of branch points (nodes) present
on dendrites
Spine number Number of spines on dendritic tree
Spine density Total spine number/total dendritic length
RC spread Distance between most distal co-ordinates in
RC axis
DV spread Distance between most distal co-ordinates in
DV axis
ML spread Distance between most distal co-ordinates in
ML axis
RC/DV spread Ratio of RC to DV spread
K dimension Measure of how dendritic tree fills space using
nested cubes method
Number of Sholl sections Number of concentric spheres originating from
soma and increasing by 50mm that contain the
total dendritic tree
Sholl length, 50-250 mm
(n 5 5)
Length of dendrite contained in the first to fifth
50 mm Sholl sections
Dendritic Sholl node density Total number of nodes divided by number of
dendritic Scholl sections
Dendritic Sholl density Total dendritic length/number of dendritic Sholl
sections
Sholl node count,
50-250 mm (n 5 5)
Number of branch points contained in the first
to fifth 50 mm Sholl sections
Node distance along process,
50-250 mm, .250 mm
(n 5 6)
Number of nodes along dendrite in 50 mm
intervals from soma or .250 mm
Dendritic torsion ratio Total dendrite length/total dendrite length in
a fan-in diagram
Convex hull area Area of a convex hull on a 2-dimensional
projection of dendritic tree
Convex hull perimeter Perimeter of a 2-dimensional convex hull
Convex hull volume Volume of a 3-dimensional convex hull around
dendritic tree
Convex hull surface area Surface area of a 3-dimensional convex hull
around dendritic tree
Planar angle average The average of the planar angles of dendritic
tree
Planar angle SD A measure of variation of planar angles
Local angle average Average of the local angles of a dendritic tree
Local angle SD A measure of variation of local angles
Spline angle average Average of the spline angles of a dendritic tree
Spline angle SD A measure of variation of spline angles
Average tortuosity of
segments
Average tortuosity (ratio of segment length to
distance between endpoints) of dendritic
segments
SD of segments SD of dendritic segment tortuosity
Average tortuosity of nodes Average tortuosity between nodes
SD of nodes SD of tortuosity between nodes
Layer length laminae I, IIo,
IIi, III (n 5 4)
Length of dendrite contained in each lamina/
sublamina
The first column lists the 55 parameters used for cluster analysis. Note that some rows include more than 1
parameter, and for these, n5 the number of parameters. The second column gives a brief definition of these
parameters.
DV, dorsoventral; ML, mediolateral; RC, rostrocaudal.
Figure 6. Cluster analysis of somatodendritic morphological parameters for
neuropeptide Y–green fluorescent protein (NPY-GFP) neurons and PrP-GFP
neurons in lamina II. (A) Scree plot of the eigenvalues derived from the principal
component analysis of the 55 morphological parameters listed in Table 5. The
first 5 factors accounted for 61% of the total variance. (B) Ward’s method of
unsupervised hierarchical clustering for the 20 NPY-GFP cells with well-
labelled dendrites and cell bodies in lamina II, and 70 lamina II PrP-GFP cells
reported in Ganley et al.13 Note that the NPY-GFP cells are interspersed
among the PrP-GFP cells and are not found in separate clusters.
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therefore likely that this cell innervated at least 3 different lamina III
ALT neurons. For both cells, each axon accounted for only a small
proportion of the boutons within the NPY bundles, which
suggests that several NPY cells innervate each ALT neuron. We
also found that in both cases, most axonal boutons belonging to
the cell were located outside the NPY bundles, indicating that
lamina III ALT neurons are not their only postsynaptic targets.
PrP-GFP cells in lamina II give rise to axons that innervate
projection neurons in lamina I, but we found that these cells also
gave rise to numerous boutons in lamina II, which contains few
dendrites of projection neurons.13 Taken together with the
present findings, this suggests that although there are inhibitory
interneurons that preferentially target specific types of projection
cell, these projection cells represent only aminority of the synaptic
output from the interneurons.
4.3. Functions of NPY–expressing interneurons
Because the NPY-expressing cells in laminae I-III are
GABAergic,3,22,50,71 actions on their target neurons can be
mediated through both GABAergic (synaptic) transmission and
volume transmission involving NPY acting on Y1 and Y2
receptors in the dorsal horn.4 The actions of NPY are likely to
be complex, as the Y1 receptor is present on a wide variety of
spinal neurons, whereas both Y1 and Y2 receptors are expressed
by primary afferents. A recent study reported that NPY depletion
in adult mice did not alter acute pain thresholds but could prolong
or reinstate hyperalgesia and allodynia in neuropathic and
inflammatory models.58 This suggests that NPY may have little
effect on sensory processing under normal conditions, but that
tonic release is antinociceptive in pathological pain states.
However, interpreting the mechanisms of action of NPY in
chronic pain is complicated because it is upregulated in primary
afferents after peripheral nerve injury,68 and in dorsal horn
neurons in inflammatory pain states.30 It is therefore not known
how much of its antinociceptive action results from peptide
released by the NPY-expressing inhibitory interneurons.
Although we seldom found NPY-GFP cells with monosynaptic
input from TRPV1-positive afferents, we had previously reported
that 40%of NPY-immunoreactive neurons in laminae I-II of the rat
showed pERK in response to capsaicin.46 In adult mice, TRPV1 is
expressed by peptidergic C nociceptors, but not by those that
Figure 7. Innervation of neuropeptide Y (NPY) bundles by the axon of a recorded NPY–green fluorescent protein cell. (A) A projected confocal image stack (72
optical sections at 0.5 mm z-spacing) shows staining for NPY (green) and calcitonin gene-related peptide (CGRP, blue), together with Neurobiotin (NB, red) from
a parasagittal section that contains part of the axon of a recorded cell. Axons containing NPY or CGRP form plexuses in lamina II (seen in the upper part of the
image), and also distinct intermingled bundles in lamina III. Three of these bundles are located in the boxes, which correspond to the fields shown in (B), (C), and (D),
and these are located approximately 150 to 200 mm apart along the rostrocaudal axis. (B–D) Higher magnification views of these 3 bundles. Note the presence of
part of the axon of the recorded cell in each of these bundles, which can be seen more clearly when only NB is revealed (B’–D’). Many of the boutons belonging to
this cell showed strong NPY-immunoreactivity, and this is illustrated in the inset in (C)’ (projection of 12 optical sections at 0.5 mm z-spacing), which shows
a magnified view of the area in the box. In addition to contributing to these bundles of NPY-immunoreactive axons, the axon of the recorded cell also gives rise to
branches that are not associated with the bundles, indicated with the arrow in (A). Scale bars: (A) 50 mm; (B–D) 25 mm.
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lack neuropeptides and express the Mas-related protein Mrgd,79
whereas in rat, TRPV1 is expressed by both populations.7 The
apparent species difference in responsiveness to capsaicin may
therefore reflect innervation of NPY cells by nonpeptidergic C
nociceptors, which would express TRPV1 in rat, but not mouse.
We found that most NPY cells in lamina III had dorsally directed
dendrites that entered the superficial dorsal horn (where C fibres
terminate) and that some of these received monosynaptic C-fibre
input. Among the potential sources for capsaicin-insensitive
(TRPV12) C-fibre input are TRPM81 cold-sensitive afferents,9
nonpeptidergic (C-Mrgd1) nociceptors,79 and C–low-threshold
mechanoreceptors.55 Our finding that NPY-GFP cells did not
respond to icilin indicates that they are unlikely to be innervated by
cold-sensitive afferents. Although we could not distinguish
between the other 2 possibilities, some of the cells with
capsaicin-insensitive monosynaptic C-fibre input were located
in themedial part of the L4-5 segments, an area that is innervated
by glabrous skin, which lacks C–low-threshold mechanorecep-
tors.34 It is therefore likely that some lamina III NPY cells are
innervated by C-Mrgd afferents, which are believed to be
important for mechanical nociception.8 This is consistent with
the activation of lamina III NPY cells by mechanical noxious
stimuli, as revealed with pERK. Taken together with our previous
findings,46 these results suggest that many of the NPY neurons in
laminae I-II, and also some of those in lamina III, respond to
noxious stimuli and that these responses are transmitted at least
in part by C-Mrgd afferents. The targets of the NPY cells include
nociceptive-activated projection neurons,43 and also interneur-
ons in the superficial laminae. They would therefore be well-
placed to attenuate pain and limit its spread from the site of
injury,51 by inhibiting excitatory interneurons and projection cells
in nociceptive pathways, both through their GABAergic synapses
and through NPY receptors. Because many of the NPY-
expressing inhibitory interneurons are likely to respond to noxious
stimuli, they may be less important for the separation of sensory
modalities51 that prevents tactile stimuli from being perceived as
painful under normal conditions.72
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